20.02.2015 • NewsAir Productsbenzoic acidcoalescents

Emerald Kalama Appoints Tsai as Director, Product Commercialization

Daniel Tsai, Director, product commercialization
Daniel Tsai, Director, product commercialization

Daniel Tsai has been appointed to the new position of director, product commercialization at Emerald Kalama Chemical, a business group of Emerald Performance Materials. He takes on this role to drive continued growth for the group's line of K-FLEX low-VOC, high solvating plasticizers and coalescents. Tsai, who has more than 25 years of experience in advanced materials, including leadership roles in operations, R&D, marketing, business development and commercialization, will provide leadership for the commercial development process as the business expands its range of products and applications.

Prior to joining Emerald, Tsai founded Novana, Inc., a polymeric materials firm, where he also served as CEO. He also held a variety of technical, marketing, and strategic planning roles at Imerys, Kimberly-Clark, Air Products & Chemicals and Nan-Ya Plastics Co. Tsai holds a Ph.D. and an M.S. in Chemical Engineering and an Executive M.B.A. from Kellogg School of Management, all from Northwestern University, as well as a B.S. in Chemical Engineering from the National Cheng-Kung University, Taiwan.

Emerald Kalama Chemical also produces sodium and potassium benzoate, benzoic acid and intermediates, and specialty flavor and fragrance ingredients, which the company sells globally through its distribution partners. The business has manufacturing operations in Kalama, Wash. and in Rotterdam, Netherlands.

 

 

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.